US Stocks
/
Tarsus Pharmaceuticals, Inc. Share Price

Tarsus Pharmaceuticals, Inc. Share Price

NASDAQ: TARS | Mid Cap
$72.09
+$1.29 (1.82%) Last updated on 29 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Tarsus Pharmaceuticals, Inc. Stock Performance

Open
$70.30
Prev. Close
$70.80
Circuit Range
N/A
Day Range
$70.30 - $72.42
Year Range
$54.18 - $91.44
Volume
20,202
Average Traded
$71.57

Tarsus Pharmaceuticals, Inc. Share Price Today

As of 29 October 2026, Tarsus Pharmaceuticals, Inc.'s share price is $72.09. The stock opened at $70.30, compared to its previous close of $70.80. During today's trading session, Tarsus Pharmaceuticals, Inc.'s share price traded between $70.30 and $72.42, with an average price of $71.36. Over the past 52 weeks, the stock has recorded a high of $91.44 and a low of $54.18. In terms of performance, Tarsus Pharmaceuticals, Inc.'s share price has risen by 13.17% over the last six months and is up 4.61% on a year-on-year basis.

Tarsus Pharmaceuticals, Inc. Share Price Chart

$70.30$72.42
L
Show Current Price
H

Tarsus Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.01B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.00
Revenue (TTM)
$451.36B
Return On Equity (TTM)
-13.54%
Profit Margin
-14.67%
Debt to Equity
0.21
Quarterly Earnings Growth YoY
-47.34%

Tarsus Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$118.70$151.67$162.05$173.91
Net Profit-$12.59-$8.17-$7.65-$18.55
Net Profit Margin-10.61%-5.39%-4.72%-10.67%
Income ChangeN/A35.11%6.36%-142.48%

Tarsus Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$25.82$17.45$182.95$451.36
Net Profit-$62.09-$135.82-$115.37-$66.22
Net Profit Margin-240.47%-778.34%-63.06%-14.67%
Income ChangeN/A-118.75%15.06%42.60%

About Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Tarsus Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$79.03
$72.03
-8.15%
Sep 2026
$74.11
$78.42
+8.99%
Aug 2026
$60.15
$71.95
+22.02%
Jul 2026
$65.04
$58.97
-6.18%
Jun 2026
$59.26
$62.85
+5.92%
May 2026
$62.60
$59.34
-6.84%
Apr 2026
$70.71
$63.70
-9.09%
Mar 2026
$74.11
$70.07
-7.20%
Feb 2026
$65.19
$75.51
+16.98%
Jan 2026
$81.56
$64.55
-21.29%
Dec 2025
$80.00
$82.02
+2.24%
Nov 2025
$69.25
$80.22
+16.41%

TARS Share Price FAQs

What is Tarsus Pharmaceuticals, Inc. share price today?

chevron-up
Tarsus Pharmaceuticals, Inc. share price today is $72.09 as on October 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Tarsus Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Tarsus Pharmaceuticals, Inc. stock is $91.44, while the 52 week low is $54.18 as of 29 Oct '26.

What is TARS's market capitalisation today?

chevron-up
TARS market capitalisation is $3.01B as of October 29, 2026, at 12:02 pm IST.

What is TARS's net income for the last quarter?

chevron-up
TARS's net income for the last quarter is -18.55B USD.

What is the 5 year returns of TARS?

chevron-up
The 5 year returns of TARS is 159.69% as on 29 Oct '26.

What is the high & low stock price of TARS today?

chevron-up
TARS stock price hit a high of $72.42 and low of $70.30 as of 29 Oct '26.

Can I buy TARS shares in India?

chevron-up
Yes. You can buy TARS in India by opening an international trading account.